MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo
暂无分享,去创建一个
Stephanie A. Santorico | R. Spritz | B. Palmer | H. Erlich | G. Cavalli | L. Dagna | C. Dinarello | C. Neff | C. Holcomb | Daniel Yorgov | Ying Jin | M. Hayashi | Isak W. Tengesdal | M. Rastrou
[1] G. Cavalli,et al. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. , 2015, Rheumatology.
[2] Yakir A Reshef,et al. Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.
[3] Effie W Petersdorf,et al. High HLA-DP Expression and Graft-versus-Host Disease. , 2015, The New England journal of medicine.
[4] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[5] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[6] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[7] M. Daly,et al. Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.
[8] M. Carrington,et al. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. , 2014, Blood.
[9] Han Xu,et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.
[10] Morgan C. Giddings,et al. Defining functional DNA elements in the human genome , 2014, Proceedings of the National Academy of Sciences.
[11] A. Stark,et al. Transcriptional enhancers: from properties to genome-wide predictions , 2014, Nature Reviews Genetics.
[12] L. C. M. Ortigosa,et al. Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report* , 2014, Anais brasileiros de dermatologia.
[13] M. Leandro,et al. Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab , 2013, Dermatologic therapy.
[14] David Heckerman,et al. Influence of HLA-C Expression Level on HIV Control , 2013, Science.
[15] R. Spritz,et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome , 2013, Proceedings of the National Academy of Sciences.
[16] William Stafford Noble,et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors , 2012, Genome research.
[17] Xiao-hong Wang,et al. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. , 2012, World journal of gastroenterology.
[18] M. Picardo,et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.
[19] Jo Lambert,et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo , 2012, Nature Genetics.
[20] Richard Apps,et al. A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection , 2012, Journal of Virology.
[21] K. Alghamdi,et al. Treatment of generalized vitiligo with anti-TNF-α Agents. , 2012, Journal of drugs in dermatology : JDD.
[22] A. Bosserhoff,et al. Meeting report from the 2011 international melanoma congress, Tampa, Florida , 2012, Pigment cell & melanoma research.
[23] E. Wherry,et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T cell accumulation in the skin , 2011, The Journal of investigative dermatology.
[24] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[25] K. Alghamdi,et al. Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab , 2011, Journal of cutaneous medicine and surgery.
[26] Matthew W. Anderson,et al. A multi-site study using high-resolution HLA genotyping by next generation sequencing. , 2011, Tissue antigens.
[27] P. Majumder,et al. DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture , 2010, Genes and Immunity.
[28] R. Young,et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.
[29] Sheri L. Riccardi,et al. Common variants in FOXP1 are associated with generalized vitiligo , 2010, Nature Genetics.
[30] Jo Lambert,et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. , 2010, The New England journal of medicine.
[31] R Higuchi,et al. High-resolution, high-throughput HLA genotyping by next-generation sequencing. , 2009, Tissue antigens.
[32] G. Hon,et al. Predictive chromatin signatures in the mammalian genome. , 2009, Human molecular genetics.
[33] A. Drosos,et al. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors , 2009, Scandinavian journal of rheumatology.
[34] Jerzy K. Kulski,et al. The HLA genomic loci map: expression, interaction, diversity and disease , 2009, Journal of Human Genetics.
[35] Sue Povey,et al. Gene map of the extended human MHC , 2004, Nature Reviews Genetics.
[36] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[37] K. Schroder,et al. Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.
[38] M. Netea,et al. The Role of Endogenous Interleukin (IL)-18, IL-12, IL-1β, and Tumor Necrosis Factor-α in the Production of Interferon-γ Induced by Candida albicans in Human Whole-Blood Cultures , 2002 .
[39] M. Netea,et al. The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures. , 2002, The Journal of infectious diseases.
[40] Philippa Marrack,et al. Autoimmune disease: why and where it occurs , 2001, Nature Medicine.
[41] B. Rocha,et al. Peripheral T cell survival. , 1999, Current opinion in immunology.
[42] H. Grey,et al. The minimal number of antigen‐major histocompatibility complex class II complexes required for activation of naive and primed T cells , 1997, European journal of immunology.
[43] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[44] M. Croft,et al. A direct role for IFN-gamma in regulation of Th1 cell development. , 1996, Journal of immunology.
[45] Antonio Lanzavecchia,et al. T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.
[46] T. Espevik,et al. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha , 1987, The Journal of experimental medicine.